Furthermore, studies showed that miR-22-3p regulated the amyloid β (Aβ) deposition in mouse model of AD by targeting mitogen-activated protein kinase 14 [16], while miR-22 regulated the AD silence disease neuroinflammation [17]. This evidence concerns the gene MAPK14 and Alzheimer disease.